AllianceBernstein
ONC

AllianceBernstein’s BeOne Medicines Ltd ONC Stock Holding History

AllianceBernstein’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,857
Closed -$265K – 3271
2024
Q2 		$265K Buy
1,857
+381
+26% +$58.7K ﹤0.01% 2961
2024
Q1 		$231K Sell
1,476
-8,753
-86% -$1.41M ﹤0.01% 2896
2023
Q4 		$1.84M Buy
10,229
+6,600
+182% +$1.19M ﹤0.01% 1983
2023
Q3 		$653K Buy
3,629
+1,205
+50% +$238K ﹤0.01% 2438
2023
Q2 		$432K Buy
+2,424
New +$558K ﹤0.01% 2712
2022
Q2 		– Sell
-15,584
Closed -$2.94M – 3404
2022
Q1 		$2.94M Buy
15,584
+10,477
+205% +$2.23M ﹤0.01% 1861
2021
Q4 		$1.38M Buy
+5,107
New +$1.72M ﹤0.01% 2343
2021
Q3 		– Sell
-1,634
Closed -$561K – 3355
2021
Q2 		$561K Buy
+1,634
New +$541K ﹤0.01% 2771
2021
Q1 		– Sell
-808
Closed -$209K – 3321
2020
Q4 		$209K Sell
808
-126,658
-99% -$34.9M ﹤0.01% 2978
2020
Q3 		$36.5M Sell
127,466
-179,681
-59% -$42.2M 0.02% 628
2020
Q2 		$57.9M Buy
307,147
+3,959
+1% +$644K 0.03% 477
2020
Q1 		$37.3M Sell
303,188
-1,767
-0.6% -$276K 0.03% 526
2019
Q4 		$50.5M Sell
304,955
-110,134
-27% -$18.3M 0.03% 540
2019
Q3 		$50.8M Buy
415,089
+25,015
+6% +$3.32M 0.03% 519
2019
Q2 		$48.4M Buy
390,074
+1,361
+0.4% +$173K 0.03% 550
2019
Q1 		$51.3M Buy
388,713
+11,267
+3% +$1.52M 0.03% 515
2018
Q4 		$52.9M Buy
377,446
+98,116
+35% +$13M 0.04% 455
2018
Q3 		$48.1M Buy
279,330
+34,750
+14% +$5.84M 0.03% 536
2018
Q2 		$37.6M Sell
244,580
-7,444
-3% -$1.33M 0.03% 608
2018
Q1 		$42.3M Sell
252,024
-179,850
-42% -$24.4M 0.03% 534
2017
Q4 		$42.2M Sell
431,874
-67,682
-14% -$6.2M 0.03% 541
2017
Q3 		$51.7M Buy
499,556
+335,718
+205% +$25M 0.04% 475
2017
Q2 		$7.37M Buy
+163,838
New +$6.46M 0.01% 1030

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

AllianceBernstein's ONC Position: Q3 2024 in Review

AllianceBernstein sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 1,857 shares — an estimated $265K sold.

AllianceBernstein first reported a position in ONC in Q2 2017 and held it in 23 quarters. The position peaked at $57.9M in Q2 2020. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • AllianceBernstein reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • AllianceBernstein sold 1,857 BeOne Medicines Ltd shares in Q3 2024, an estimated $265K.
  • AllianceBernstein first reported a position in BeOne Medicines Ltd in Q2 2017 and held it in 23 quarters.
  • AllianceBernstein's BeOne Medicines Ltd position peaked at $57.9M in Q2 2020.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on AllianceBernstein's 13F filing for Q3 2024, filed 14 Nov 2024.